Rishika Prasad

846 total citations
5 papers, 239 citations indexed

About

Rishika Prasad is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Rishika Prasad has authored 5 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Rishika Prasad's work include interferon and immune responses (2 papers), Cytokine Signaling Pathways and Interactions (1 paper) and Ubiquitin and proteasome pathways (1 paper). Rishika Prasad is often cited by papers focused on interferon and immune responses (2 papers), Cytokine Signaling Pathways and Interactions (1 paper) and Ubiquitin and proteasome pathways (1 paper). Rishika Prasad collaborates with scholars based in United States, India and Spain. Rishika Prasad's co-authors include Soumya Chatterjee, Mohan G. Vairale, Rajesh Kumar Prasad, Sibnarayan Datta, Sonika Sharma, Michael A. Curran, Cristian Coarfa, Casey R. Ager, Colm R. Duffy and Kimal Rajapakshe and has published in prestigious journals such as Cancer Research, Cancers and Neuro-Oncology.

In The Last Decade

Rishika Prasad

5 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rishika Prasad United States	4	127	104	62	49	40	5	239
Medeea C. Popescu United States	4	148 1.2×	108 1.0×	16 0.3×	15 0.3×	45 1.1×	6	231
Peter Mayrhofer Austria	7	92 0.7×	212 2.0×	34 0.5×	27 0.6×	36 0.9×	7	315
Sonja Lechleitner Austria	6	58 0.5×	71 0.7×	112 1.8×	30 0.6×	48 1.2×	7	259
Sadiya Parveen United States	8	46 0.4×	109 1.0×	88 1.4×	53 1.1×	10 0.3×	12	287
C. Cheng Kao United States	9	66 0.5×	126 1.2×	37 0.6×	19 0.4×	8 0.2×	10	352
Olga V. Zubkova Russia	8	23 0.2×	64 0.6×	42 0.7×	22 0.4×	42 1.1×	24	186
Jordan Pischimarov Germany	7	59 0.5×	177 1.7×	20 0.3×	44 0.9×	12 0.3×	8	373
Willem de Koning Netherlands	9	32 0.3×	127 1.2×	40 0.6×	48 1.0×	11 0.3×	20	246
Avantika Dhabaria United States	9	30 0.2×	353 3.4×	72 1.2×	20 0.4×	29 0.7×	20	463
Daniel Yee United Kingdom	5	42 0.3×	267 2.6×	122 2.0×	65 1.3×	17 0.4×	5	383

Countries citing papers authored by Rishika Prasad

Since Specialization

Citations

This map shows the geographic impact of Rishika Prasad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rishika Prasad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rishika Prasad more than expected).

Fields of papers citing papers by Rishika Prasad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rishika Prasad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rishika Prasad. The network helps show where Rishika Prasad may publish in the future.

Co-authorship network of co-authors of Rishika Prasad

This figure shows the co-authorship network connecting the top 25 collaborators of Rishika Prasad. A scholar is included among the top collaborators of Rishika Prasad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rishika Prasad. Rishika Prasad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Chen, Chao-Hsien, Genevieve Hartley, Brian J. Engel, et al.. (2023). Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human disease. Neuro-Oncology. 25(8). 1415–1427. 7 indexed citations

2.

Ager, Casey R., Kimal Rajapakshe, Maria Emilia Di Francesco, et al.. (2021). High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege. Journal for ImmunoTherapy of Cancer. 9(8). e003246–e003246. 47 indexed citations

3.

Prasad, Rishika, et al.. (2020). Abstract PR06: The glutaminase inhibitor CB-839 potentiates antimelanoma activity of standard-of-care targeted therapies and immunotherapies. Cancer Research. 80(19_Supplement). PR06–PR06. 1 indexed citations

4.

Ramirez‐Peña, Esmeralda, James M. Arnold, Robiya Joseph, et al.. (2019). The Epithelial to Mesenchymal Transition Promotes Glutamine Independence by Suppressing GLS2 Expression. Cancers. 11(10). 1610–1610. 36 indexed citations

5.

Sharma, Sonika, Soumya Chatterjee, Sibnarayan Datta, et al.. (2016). Bacteriophages and its applications: an overview. Folia Microbiologica. 62(1). 17–55. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact